Prostate Cancer

 

Tips&Tools

About
 Daily News from Top Searches
Popular Searches
Tips on Searching
SearchMedica for IPhone
Go To SearchMedica
Sign Up For Our Newsletter



ProstateCancerNews

Medicare to Cover FDG-PET for Most Cancers
www.medpagetoday.com - 3/14/13
(MedPage Today) -- WASHINGTON, D.C. -- Medicare will pay for so-called FDG-PET scans for monitoring malignant tumors in routine practice, except in prostate cancer, according to a proposed decision memo.
Mixed Results with New Prostate Ca Tx
www.medpagetoday.com - 2/17/13
ORLANDO (MedPage Today) -- More than 90% of men with high-risk castration-resistant prostate cancer had significant biochemical responses to a novel anti-androgen, results of small clinical trial showed.
Zytiga Prolongs Prostate Cancer Survival
www.medpagetoday.com - 2/15/13
ORLANDO (MedPage Today) -- Survival improved and disease progression slowed in men with metastatic castration-resistant prostate cancer treated in first line with abiraterone acetate (Zytiga).
Early Radiation Boosts Prostate Cancer Survival
www.medpagetoday.com - 2/14/13
ORLANDO (MedPage Today) -- Immediate radiation therapy after radical prostatectomy led to a 50% increase in long-term biochemical progression-free survival for patients with locally advanced prostate cancer, according to a study reported here.
Steroids Negate Benefits of Prostate Ca Tx
www.medpagetoday.com - 2/14/13
ORLANDO (MedPage Today) -- Men with castration-resistant prostate cancer had worse survival when treated with corticosteroids, regardless of their primary treatment, a post-hoc analysis of a randomized trial showed.

Result Pages: 1 2 3 4 5 6 7 8 9 10 Next


FeaturedArticles

April 26, 2013
Prostate Cancer Risk Higher in Obese Men After Benign Biopsy
A case-control study of almost 500 men suggests that obese men who have had a benign prostate biopsy have a greater risk of prostate cancer in the future. More »
April 22, 2013
In Mouse Model, Imaging Strategy Follows Prostate Cancer Bone Metastasis Response to Cabozantinib
A mouse model of bone metastasis can be used to follow real-time response to therapeutics in preclinical development, such as cabozantinib, according to results presented in the poster session of the 2013 AACR annual meeting. More »
April 18, 2013
Zoledronic Acid Did Not Prevent Bone Metastases in High-Risk Prostate Cancer
The use of zoledronic acid (Zometa) had no effect on the prevention of bone metastases in patients with high-risk prostate cancer, according to the first results of the Zometa European Study, or ZEUS, presented at the European Association of Urology 28th Annual Congress in Milan, Italy. More »
April 18, 2013
Is Docetaxel Still a Stalwart in Prostate Cancer?
New alternatives to docetaxel (including cabozanitib and abiraterone) are hot on its heels for treatment of prostate cancer, and another drug has potential to address docetaxel resistance. More »
April 15, 2013
Value Judgments in Diagnostic Imaging for Prostate Cancer: A Paradox in Healthcare Reform
Only the possibility of increasing survival with better tumor localization and staging is probable with multiparametric MRI—and improved survival with MR imaging in prostate cancer has not been shown in a clinical trial or meta-analysis to date. More »
Showing 6 - 10 of 670 results.
Page of 134
First Last

PubMed

Hits identified in library screening demonstrate selective CYP17A1 lyase inhibition.
pubmed.gov - 2/28/13
Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course.
pubmed.gov - 2/14/13
Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
pubmed.gov - 2/14/13
Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma.
pubmed.gov - 2/14/13
Urologic Clinics of North America. Multidisciplinary management of urinary stone disease. Foreword.
pubmed.gov - 1/31/13
More Results

ClinicalTrials

Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells
neuro-oncology.oxfordjournals.org - 1/17/13
Prostate Cancer Intervention Versus Observation Trial (PIVOT):A Randomized Trial Comparing Radical Prostatectomy Versus Palliative Expectant Management for the Treatment of Clinically Localized Prostate Cancer
www.clinicaltrials.gov -
Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer
www.clinicaltrials.gov -
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer
www.clinicaltrials.gov -
Biobank Prostate Cancer: Storing Blood and Protein of Patients With Prostate Cancer
www.clinicaltrials.gov -
More Results


TopicIndex

PracticeGuidelines

Guide to Clinical Preventive Services, 2010-2011: Section 2
www.ahrq.gov - 8/31/10
Table 3. Men's Preferences and Practices for Prostate Cancer Screening or Treatment
www.acponline.org -
Figure 3. Trends in the proportion of men with nonmetastatic prostate cancer who were treated with radical prostatectomy, external-beam radiation, and other therapies in three age groups.
www.acponline.org -
Table 1. Prostate Cancer Treatment and Hospitalization Following Prostate Biopsy
www.acponline.org -
Figure 2. Informational pamphlet about early prostate cancer detection and treatment.
www.acponline.org -
Trends in the Use of Radical Prostatectomy for Treatment of Prostate Cancer
www.acponline.org -
More Results


FromPhysiciansPractice

Five Steps to Improving Patient Access
Judy Capko,  May 21, 2013
Patient access is getting increased attention through reform initiatives. Here are five steps you can take to make sure patients get appropriate access to care in your office.
Growing HIPAA Threat – Ignore Windows XP at Your Own Peril
Marion K. Jenkins,  May 21, 2013
Chances are good that you have some major ticking software time bombs lurking in your medical practice's computer environment, namely Windows XP and Server 2003.
Finding Physician Work-Life Balance in the Small Moments
Jennifer Frank, MD,  May 21, 2013
At my practice and at home, things are always busy. There's laundry or homework, or a patient with needs.
Three Areas to Reduce Costs at Your Medical Practice
Greg Mertz,  May 19, 2013
By taking a hard look at reducing costs for staffing, overhead, and technology at your medical practice, you may see increased physician compensation.
Dos and Don’ts for Starting a Physician Blog
Michael Woo-Ming, MD,  May 18, 2013
Starting a physician blog can provide your medical practice with marketing benefits, but it's important to do it right.
 

 


PatientResources

American Cancer Society
Prostate Cancer


National Cancer Institute
General Information About Prostate Cancer


National Comprehensive Cancer Network
Guidelines for Patients - Prostate Cancer